We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

000009:SSEChina Baoan Group Co., Ltd. Analysis

Data as of 2026-05-28 - not real-time

CN¥7.45

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

China Baoan Group is trading at CNY 7.45, well beneath its 20‑day (≈8.15), 50‑day (≈8.59) and 200‑day (≈9.78) simple moving averages, signaling a sustained bearish price trend. The RSI sits at just 25, indicating oversold conditions, while the MACD line is negative and the histogram is shrinking, confirming bearish momentum. Volume has been on a downtrend and 30‑day volatility is high at over 31%, suggesting price swings may continue. The nearest support sits at CNY 7.30, with resistance near CNY 9.32, framing a narrow trading range.
Fundamentally, the stock appears severely overvalued: a trailing PE of 372 dwarfs the industry average of 30, and the DCF‑derived fair value of about CNY 6.39 is well below the market price. Forward earnings imply a more reasonable PE of ~8, but the company’s profit margin is a meager 0.2% and free cash flow is negative, reflecting cash‑draining operations. Debt is high (debt‑to‑equity ≈ 93%) and exceeds cash reserves, while the dividend payout ratio exceeds 100%, making the current 0.4% yield unsustainable. Revenue growth of ~20% offers a glimpse of top‑line momentum, yet the weak earnings and capital structure raise serious concerns.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • Price below all major SMAs
  • Bearish MACD and low RSI
  • Extreme overvaluation (PE 372 vs industry 30)

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Revenue growth in EV battery segment
  • High debt burden limiting flexibility
  • Potential for earnings improvement if cash flow turns positive

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Long‑term tailwinds in electric‑vehicle supply chain
  • Structural challenges from leverage and negative free cash flow
  • Uncertainty around regulatory environment for conglomerates

Key Metrics & Analysis

Financial Health

Revenue Growth19.70%
Profit Margin0.22%
P/E Ratio372.5
ROE5.26%
ROA2.27%
Debt/Equity93.10
P/B Ratio1.9
Op. Cash FlowCN¥1.5B
Free Cash FlowCN¥-2215297536
Industry P/E30.0

Technical Analysis

TrendBearish
RSI25.4
SupportCN¥7.30
ResistanceCN¥9.32
MA 20CN¥8.15
MA 50CN¥8.59
MA 200CN¥9.78
MACDBearish
VolumeDecreasing
Fear & Greed Index93.32

Valuation

Fair ValueCN¥6.39
GradeOvervalued
TypeValue
Dividend Yield0.40%

Risk Assessment

Beta-0.03
Volatility31.25%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.